Showing results (11-20 of 67) with videos related to

Sort By:
Pageof 7
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|July 26, 2015
A quantitative LC-MS/MS method for determining ipragliflozin, a sodium-glucose co-transporter 2 (SGLT-2) inhibitor, and its application to a pharmacokinetic study in ratsShinji Kobuchi, Yukako Ito, Kyoka Yano, et al.
Cancer Chemotherapy and Pharmacology|April 3, 2020
Assessment of pharmacokinetic variations of capecitabine after multiple administration in rats: a physiologically based pharmacokinetic modelShuhei Sakai, Shinji Kobuchi, Yukako Ito, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|October 28, 2015
Population pharmacokinetic modelling and simulation of 5-fluorouracil incorporating a circadian rhythm in ratsShinji Kobuchi, Yukako Ito, Yuya Nakano, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|November 15, 2023
Pharmacokinetic evaluation of oxaliplatin combined with S-1 (SOX) chemotherapy in a rat model of colorectal cancer with acute kidney injury: predictive renal biomarkers for dose optimisationTakumi Tanaka, Shinji Kobuchi, Yukako Ito, et al.
European Journal of Drug Metabolism and Pharmacokinetics|February 19, 2021
A Physiologically Based Pharmacokinetic-Pharmacodynamic Model for Capecitabine in Colorectal Cancer Rats: Simulation of Antitumor Efficacy at Various Administration SchedulesShuhei Sakai, Shinji Kobuchi, Yukako Ito, et al.
Bioanalysis|June 4, 2020
A validated LC-MS/MS method for the low-level determination of pemafibrate, a novel SPPARMα, in plasmaShinji Kobuchi, Atsushi Shigemura, Yukako Ito, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|August 6, 2018
Circadian variations in the pharmacokinetics of the oral anticancer agent tegafur-uracil (UFT) and its metabolites in ratsShinji Kobuchi, Yukako Ito, Daiki Takamatsu, et al.
Pageof 7